Intermittent Dosing Insights

Researchers are exploring innovative approaches to cancer treatment by implementing "hit and run" dosing strategies. This method allows for intermittent administration of drugs like Dysatinib, potentially reducing side effects while maintaining efficacy. Additionally, studies on natural compounds like Fistin are also utilizing similar intermittent protocols, suggesting a shift in how we approach cancer therapies.